Laboratory Corporation of America Holdings Profile Avatar - Palmy Investing

Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two s…
Medical - Diagnostics & Research
US, Burlington [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
41.98 41.92 41.04 39.67 38.28 36.65 33.45 32.99 33.18 28.03 28.15 35.43 34.89 29.48 25.86
Profit Margin
11.57 11.16 9.38 10.28 9.88 8.50 5.03 7.59 12.15 7.80 7.13 11.13 14.75 8.60 3.44
Operating Margin
19.94 19.56 17.11 18.05 17.06 15.14 11.55 13.61 13.07 11.70 11.51 17.49 20.22 11.92 9.24
EPS Growth
8.26 9.44 -2.57 17.51 7.37 -10.00 -26.70 61.54 73.53 -29.70 -3.44 90.13 53.72 -42.88 -65.81
Return on Assets (ROA)
11.18 9.02 8.42 8.56 8.26 7.00 3.06 5.14 7.65 5.46 4.57 7.75 11.66 6.35 2.50
Return on Equity (ROE)
25.80 22.63 20.76 21.62 23.13 18.12 8.72 13.30 18.57 12.68 10.89 16.63 23.14 12.67 5.31
Return on Invested Capital (ROIC)
13.13 12.33 8.57 10.87 11.16 9.65 5.25 7.67 11.27 7.09 6.78 10.65 14.93 8.76 5.73
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
48.79 40.22 69.79 46.04 44.57 41.49 44.92 41.06 40.81 37.44 39.30 33.66 31.11 31.23 31.25
Debt/Equity
112.56 100.90 172.02 116.26 124.82 107.42 128.08 106.24 99.01 86.92 93.60 72.19 61.74 62.35 66.37
Debt/EBITDA
121.18 40.09 183.12 190.39 231.88 204.42 361.53 288.00 326.85 267.58 342.63 153.39 118.30 213.80 317.81
Debt/Capitalization
52.96 50.22 63.24 53.76 55.52 51.79 56.15 51.51 49.75 46.50 48.35 41.92 38.17 38.40 39.89
Interest Debt per Share USD
22.31 24.98 44.93 34.54 37.35 37.02 67.73 59.21 68.33 62.17 74.80 71.57 67.78 71.08 62.30
Debt Growth
-19.03 -52.52 235.65 19.54 12.46 1.47 111.80 -8.84 15.60 -10.39 16.88 -4.61 -6.13 -0.75 -5.41
Liquidity
Current Ratio
27.68 40.51 23.55 115.25 161.57 173.38 156.51 135.51 131.11 150.91 112.63 166.49 191.54 150.24 116.75
Quick Ratio
27.68 40.51 23.55 115.25 161.57 142.96 122.89 106.74 99.39 121.83 89.61 140.89 160.33 111.98 81.72
Cash Ratio
5.69 10.55 4.37 45.39 54.91 59.41 42.10 23.71 15.48 22.72 12.75 42.90 52.92 13.97 16.64
Operating Cash Flow Ratio
- - - - - - - - 100 - - - - - - - - - - - - - - 100 - - - -
Turnover
Inventory Turnover
3,026.44 2,810.54 2,949.10 2,827.85 2,626.45 2,730.11 3,024.50 3,148.78 3,065.64 3,437.42 3,392.85 2,132.73 2,615.00 2,229.43 1,899.81
Receivables Turnover
817.61 763.26 791.98 789.34 740.19 736.99 631.51 634.87 608.15 608.57 570.52 463.39 541.28 493.03 579.48
Payables Turnover
1,487.60 1,127.27 1,267.49 1,444.37 1,177.37 1,349.10 1,161.40 1,270.91 1,052.40 1,285.38 1,313.03 1,412.69 1,689.46 1,122.35 1,089.61
Asset Turnover
96.61 80.87 89.81 83.28 83.58 82.33 60.76 67.68 63.02 70.02 64.12 69.64 79.08 73.81 72.71
Coverage
Interest Coverage
1,487.92 1,398.29 1,083.89 1,083.07 955.54 831.42 364.82 599.00 580.26 542.87 552.64 1,179.07 1,536.78 983.86 562.98
Asset Coverage
100 400 100 100 100 100 100 100 100 100 100 200 200 200 100
Cash Flow Coverage (CFGR)
36.38 35.51 19.87 26.84 26.43 24.39 15.31 20.10 21.58 21.54 20.40 31.60 49.03 31.07 25.40
EBITDA Coverage
1,600 1,500 1,200 1,200 1,000 1,000 500 800 800 800 800 1,700 1,900 1,500 800
Dividend Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - -600 -100
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 200 200 100 100
Market Prospects
Dividend Yield
- - - - - - - - - - - - - - - - - - - - - - - - - - 1.06 1.28
Earnings Yield
7.75 7.22 7.20 8.38 8.53 6.50 4.16 6.48 9.04 8.03 5.79 9.15 9.11 6.94 2.11
Price/Earnings (P/E)
1,291.01 1,385.57 1,389.75 1,193.16 1,172.29 1,537.58 2,402.05 1,544.15 1,106.44 1,245.56 1,727.09 1,093.37 1,097.98 1,440.75 4,736.11
Price/Book (P/B)
333.03 313.60 288.50 258.01 271.10 278.68 209.46 205.32 205.44 157.89 188.02 181.78 254.09 182.52 251.39
Price/Sales (P/S)
149.40 154.56 130.32 122.67 115.81 130.75 120.90 117.25 134.39 97.12 123.13 121.71 161.92 123.87 162.78
Price/Cash Flow (P/CF)
813.32 875.31 844.15 826.88 821.62 1,063.61 1,068.25 961.37 961.48 843.19 984.83 796.79 839.41 942.21 1,491.07
End of LH's Analysis
CIK: 920148 CUSIP: 50540R409 ISIN: US50540R4092 LEI: - UEI: -
Secondary Listings